T48.295
Adverse effect of other drugs acting on muscles
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T48.295 refers to adverse effects caused by medications that specifically impact muscle tissue. These effects can range from mild discomfort to severe muscle damage, often requiring medical attention. Such reactions can occur with various drugs and may vary in severity based on individual health factors, dosage, and duration of use.
Causes & Symptoms
Clinical Causes: Use of certain antibiotics, such as quinolones and macrolides Statin medications used to lower cholesterol levels Certain antifungal drugs and antiretroviral medications Muscle relaxants prescribed for spasms or tension Chemotherapy agents that target rapidly dividing cells Immunosuppressants and corticosteroids Other medications with known muscle-related adverse effects
Key Symptoms: Muscle weakness or fatigue Muscle pain or discomfort Swelling or tenderness in muscles Trouble moving affected limbs Rhabdomyolysis in severe cases, characterized by muscle breakdown and dark urine Elevated levels of muscle enzymes such as creatine kinase (CK) in blood tests Feeling of stiffness or cramping in muscles
Diagnostic & Treatment
Diagnosis Path: Diagnosing adverse drug reactions affecting muscles involves a combination of patient history, medication review, physical examination, and laboratory tests. Healthcare providers may order blood tests to identify elevated muscle enzymes and perform imaging studies if necessary. Discontinuing the suspected medication often plays a key role in confirming the diagnosis, with improvement in symptoms supporting the diagnosis of drug-induced muscle effects.
Treatment Protocols: Managing adverse effects on muscles caused by medications typically involves stopping or adjusting the dosage of the suspected drug. Supportive care may include pain relievers, physical therapy, and hydration to help flush out muscle breakdown products. In severe cases, such as rhabdomyolysis, hospitalization and more intensive interventions may be necessary to prevent complications like kidney damage. It is essential to monitor muscle enzymes and kidney function during recovery.
Clinical Advice & FAQs
Billing Guidance
Is T48.295 a billable ICD-10 code?
Yes, T48.295 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T48.295?
Clinical documentation must specify the nature of Adverse effect of other drugs acting on muscles and any associated comorbidities for accurate reporting.
Cite this Clinical Reference